BERREY M MICHELLE (President, R&D and CMO) reported 1 transaction at INTERCEPT PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 6/16/2023ACC: 0001104659-23-072210
Officer· President, R&D and CMO
Since Jun 2021
-1.25K
Net shares
Net seller
$15.0K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
1.25K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.25K
Price / share
$12.04
Trade value
$15K
% of position
1.5%
6/14/2023
82.63K→81.39K
Total
Net shares
−1.25K
Net value
-$15K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/14/2023 | F · Tax Withholding | −1.25K | $12.04 | $15K | 1.5% | 82.63K | 81.39K |
| Total | −1.25K | -$15K | ||||||
Derivative Transactions0
No derivative transactions reported